Pub Date : 2025-12-30DOI: 10.1016/j.rmed.2025.108627
Anuraag Sah , Matthew I. Derakhshesh , Hannah D. Bozell , Minahil Wasim , Fatima Javed , Peter Kirkpatrick , Emilio J. Fabian , Boris Shkolnik , Paul J. Feustel , Kurt Hu , Marc A. Judson , Radmila Lyubarova , Mikhail Torosoff , Amit Chopra
Rationale
Differentiating between congestive heart failure-related pleural effusion (CHF-PE) and non-CHF-PE is clinically important. However, this distinction can be challenging and often requires thoracentesis. Role of transthoracic echocardiography in the diagnosis of CHF-PE has never been evaluated.
Objective
Assess the diagnostic performance of echocardiography in differentiating CHF-PE from non-CHF-PE.
Methods
This is a single-center retrospective case-control study of patients with pleural effusions classified as either CHF-PE or non-CHF-PE based on a comprehensive clinical data analysis. Traditional indicators of CHF (reduced left ventricular ejection fraction) and contemporary echocardiographic parameters of elevated left atrial pressures (enlarged indexed left atrial volume - LAVI, increased E/A and E/e’ ratios) were investigated. Echocardiographic evaluations were blinded to the clinical classification of pleural effusions.
Results
The study cohort included 167 patients; most patients (112/167) were diagnosed with non-CHF-PE. Echocardiographic parameters of E/e’ > 14, E/A > 2, LAVI ≥34 ml/m2, and LVEF <40 % had high specificity (89 %, 98 %, 80 %, and 94 %, respectively) but low to modest individual sensitivity (45 %, 12 %, 72 %, and 27 %, respectively) in diagnosing CHF-PE. In a univariate logistic regression, both E/e’ and LAVI performed well in identifying CHF-PE (AUC = 0.832 and 0.835, respectively), however, the best results were seen when E/e’ and LAVI were combined (AUC = 0.903). Whereas reduced LVEF was not helpful in identifying CHF-PE (AUC = 0.635).
Conclusion
Echocardiographic parameters indicative of elevated left atrial pressure can be helpful in diagnosis of pleural effusions associated with CHF and may reduce the need for invasive thoracentesis in selected patients with pleural effusion.
{"title":"Diagnostic accuracy of echocardiography in identifying heart failure related pleural effusions","authors":"Anuraag Sah , Matthew I. Derakhshesh , Hannah D. Bozell , Minahil Wasim , Fatima Javed , Peter Kirkpatrick , Emilio J. Fabian , Boris Shkolnik , Paul J. Feustel , Kurt Hu , Marc A. Judson , Radmila Lyubarova , Mikhail Torosoff , Amit Chopra","doi":"10.1016/j.rmed.2025.108627","DOIUrl":"10.1016/j.rmed.2025.108627","url":null,"abstract":"<div><h3>Rationale</h3><div>Differentiating between congestive heart failure-related pleural effusion (CHF-PE) and non-CHF-PE is clinically important. However, this distinction can be challenging and often requires thoracentesis. Role of transthoracic echocardiography in the diagnosis of CHF-PE has never been evaluated.</div></div><div><h3>Objective</h3><div>Assess the diagnostic performance of echocardiography in differentiating CHF-PE from non-CHF-PE.</div></div><div><h3>Methods</h3><div>This is a single-center retrospective case-control study of patients with pleural effusions classified as either CHF-PE or non-CHF-PE based on a comprehensive clinical data analysis. Traditional indicators of CHF (reduced left ventricular ejection fraction) and contemporary echocardiographic parameters of elevated left atrial pressures (enlarged indexed left atrial volume - LAVI, increased E/A and E/e’ ratios) were investigated. Echocardiographic evaluations were blinded to the clinical classification of pleural effusions.</div></div><div><h3>Results</h3><div>The study cohort included 167 patients; most patients (112/167) were diagnosed with non-CHF-PE. Echocardiographic parameters of E/e’ > 14, E/A > 2, LAVI ≥34 ml/m2, and LVEF <40 % had high specificity (89 %, 98 %, 80 %, and 94 %, respectively) but low to modest individual sensitivity (45 %, 12 %, 72 %, and 27 %, respectively) in diagnosing CHF-PE. In a univariate logistic regression, both E/e’ and LAVI performed well in identifying CHF-PE (AUC = 0.832 and 0.835, respectively), however, the best results were seen when E/e’ and LAVI were combined (AUC = 0.903). Whereas reduced LVEF was not helpful in identifying CHF-PE (AUC = 0.635).</div></div><div><h3>Conclusion</h3><div>Echocardiographic parameters indicative of elevated left atrial pressure can be helpful in diagnosis of pleural effusions associated with CHF and may reduce the need for invasive thoracentesis in selected patients with pleural effusion.</div></div>","PeriodicalId":21057,"journal":{"name":"Respiratory medicine","volume":"252 ","pages":"Article 108627"},"PeriodicalIF":3.1,"publicationDate":"2025-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145888873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-30DOI: 10.1016/j.rmed.2025.108622
Yiqin Yan , Jialong Jiang , Lihan Xiang , Jinmei Zhang , Dandan Hu , Liming Lou , Yue Sun
Background
Current therapeutic strategies for chronic obstructive pulmonary disease (COPD) remain insufficient to halt disease progression or prevent acute exacerbations. This study aimed to investigate vascular endothelial glycocalyx components (Syndecan-1, Heparan Sulfate, and Hyaluronic Acid) as biomarkers for detecting disease severity and predicting acute exacerbations (AECOPD).
Methods
100 patients with COPD and 50 healthy volunteers from the Third Affiliated Hospital of Zhejiang Chinese Medical University. The serum glycocalyx (SDC-1, HS, and HA) levels of the subjects were detected, and the differences were compared.
Results
The level of SDC-1, HS, and HA were higher in the exacerbation group than in the stable group and the control group (P < 0.05), and in the stable group than in the control group (P < 0.05). SDC-1, HS, and HA were negatively correlated with PaO2, FVC % pred, FEV1 % pred, and FEV1/FVC (P < 0.05) while positively correlating with PaCO2 (P < 0.05). The logistic regression analysis showed that SDC-1, HS, and HA were influential factors in the acute exacerbation of COPD (AECOPD). The receiver operating characteristics analysis showed that SDC-1, HS, and HA had good predictive efficacy in the AECOPD. Strong correlations between hospital stay and levels of glycocalyx were evident, especially for SDC-1, HS, signifying robust associations with prolonged hospitalization.
Conclusion
The circulating levels of glycocalyx degradation products (SDC-1, HS, and HA) were markedly elevated in AECOPD patients and demonstrated significant correlations with the severity of impaired lung function and gas exchange. Analysis revealed that these biomarkers were independent predictors of acute exacerbations and strongly associated with prolonged hospitalization. Therefore, our study provides clinical evidence that quantifying these components offers a promising, non-invasive approach for assessing disease severity and predicting outcomes in COPD.
{"title":"Clinical value of vascular endothelial glycocalyx in acute exacerbation of chronic obstructive pulmonary disease","authors":"Yiqin Yan , Jialong Jiang , Lihan Xiang , Jinmei Zhang , Dandan Hu , Liming Lou , Yue Sun","doi":"10.1016/j.rmed.2025.108622","DOIUrl":"10.1016/j.rmed.2025.108622","url":null,"abstract":"<div><h3>Background</h3><div>Current therapeutic strategies for chronic obstructive pulmonary disease (COPD) remain insufficient to halt disease progression or prevent acute exacerbations. This study aimed to investigate vascular endothelial glycocalyx components (Syndecan-1, Heparan Sulfate, and Hyaluronic Acid) as biomarkers for detecting disease severity and predicting acute exacerbations (AECOPD).</div></div><div><h3>Methods</h3><div>100 patients with COPD and 50 healthy volunteers from the Third Affiliated Hospital of Zhejiang Chinese Medical University. The serum glycocalyx (SDC-1, HS, and HA) levels of the subjects were detected, and the differences were compared.</div></div><div><h3>Results</h3><div>The level of SDC-1, HS, and HA were higher in the exacerbation group than in the stable group and the control group (P < 0.05), and in the stable group than in the control group (P < 0.05). SDC-1, HS, and HA were negatively correlated with PaO<sub>2</sub>, FVC % pred, FEV1 % pred, and FEV1/FVC (P < 0.05) while positively correlating with PaCO<sub>2</sub> (P < 0.05). The logistic regression analysis showed that SDC-1, HS, and HA were influential factors in the acute exacerbation of COPD (AECOPD). The receiver operating characteristics analysis showed that SDC-1, HS, and HA had good predictive efficacy in the AECOPD. Strong correlations between hospital stay and levels of glycocalyx were evident, especially for SDC-1, HS, signifying robust associations with prolonged hospitalization.</div></div><div><h3>Conclusion</h3><div>The circulating levels of glycocalyx degradation products (SDC-1, HS, and HA) were markedly elevated in AECOPD patients and demonstrated significant correlations with the severity of impaired lung function and gas exchange. Analysis revealed that these biomarkers were independent predictors of acute exacerbations and strongly associated with prolonged hospitalization. Therefore, our study provides clinical evidence that quantifying these components offers a promising, non-invasive approach for assessing disease severity and predicting outcomes in COPD.</div></div>","PeriodicalId":21057,"journal":{"name":"Respiratory medicine","volume":"252 ","pages":"Article 108622"},"PeriodicalIF":3.1,"publicationDate":"2025-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145885887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-30DOI: 10.1016/j.rmed.2025.108628
Mira Abou-Rjeili , Raquel Farias , Yousof Mostafavi , Benjamin Smith , Nadia Giannetti , Jean Bourbeau
Chronic Obstructive Pulmonary Disease (COPD) and Heart failure (HF) are often concomitant, they are overlooked in practice. The objectives of this study were to determine the prevalence of HF in diagnosed COPD and COPD in diagnosed HF from a specialized clinics and determine patients’ characteristics which could be used to in clinical practice for active screening.
We conducted a prospective cohort study in a specialized COPD clinic and HF clinic. Patients underwent detailed cardiopulmonary evaluation to establish diagnosis and were followed for 12 months.
The prevalence of unrecognized COPD and HF were respectively 26.1 % and 26.8 %, and these patients were older, more likely to be male and heavy smokers. COPD patients with abnormal vs those with normal echocardiography had an increased rate of mod-severe exacerbation like events (1.3 vs 0.6). They also had a higher prevalence of self-reported heart disease, diabetes, abnormal ECG, cardiovascular medication use, higher blood eosinophil and troponin but no difference on lung function, computed tomography-assessed emphysema and gas trapping, symptom burden and health status.
HF patients with abnormal vs those with normal spirometry had increased exacerbation like-events (16.7 % vs 6.3 % but reach statistical significance). They also had more heart disease, worse lung function by definition and gas trapping, higher blood eosinophil but no difference in symptom burden and health status.
In two specialized clinics the prevalence of concomitant disease -undiagnosed HF in COPD patients and undiagnosed COPD in HF patients was common. Distinctive features were limited to clinical characteristics, but specific biomarkers cannot be recommended.
慢性阻塞性肺疾病(COPD)和心力衰竭(HF)往往是合并症,在实践中被忽视。本研究的目的是确定在专门诊所诊断为慢性阻塞性肺病的心衰患病率和慢性阻塞性肺病在诊断为心衰的患者中的患病率,并确定患者的特征,这些特征可用于临床实践中的主动筛查。我们在一家专门的COPD诊所和心衰诊所进行了一项前瞻性队列研究。患者接受详细的心肺评估以确定诊断,并随访12个月。未被识别的COPD和HF患病率分别为26.1%和26.8%,这些患者年龄较大,多为男性和重度吸烟者。与超声心动图正常的COPD患者相比,超声心动图异常的COPD患者发生中度-重度加重样事件的比率增加(1.3 vs 0.6)。他们自我报告的心脏病、糖尿病、心电图异常、心血管药物使用、较高的嗜酸性粒细胞和肌钙蛋白的患病率也较高,但在肺功能、计算机断层扫描评估的肺气肿和气体潴留、症状负担和健康状况方面没有差异。肺活量异常与正常的HF患者加重样事件增加(16.7% vs 6.3%,但有统计学意义)。他们也有更多的心脏病,更差的肺功能和气体捕获,更高的血嗜酸性粒细胞,但症状负担和健康状况没有差异。在两个专科诊所中,伴发疾病——COPD患者中未确诊的HF和HF患者中未确诊的COPD的患病率很普遍。独特的特征仅限于临床特征,但不能推荐特定的生物标志物。
{"title":"Personalizing the approach for the diagnosis of patients with concomitant Chronic Obstructive Pulmonary Disease and Heart failure","authors":"Mira Abou-Rjeili , Raquel Farias , Yousof Mostafavi , Benjamin Smith , Nadia Giannetti , Jean Bourbeau","doi":"10.1016/j.rmed.2025.108628","DOIUrl":"10.1016/j.rmed.2025.108628","url":null,"abstract":"<div><div>Chronic Obstructive Pulmonary Disease (COPD) and Heart failure (HF) are often concomitant, they are overlooked in practice. The objectives of this study were to determine the prevalence of HF in diagnosed COPD and COPD in diagnosed HF from a specialized clinics and determine patients’ characteristics which could be used to in clinical practice for active screening.</div><div>We conducted a prospective cohort study in a specialized COPD clinic and HF clinic. Patients underwent detailed cardiopulmonary evaluation to establish diagnosis and were followed for 12 months.</div><div>The prevalence of unrecognized COPD and HF were respectively 26.1 % and 26.8 %, and these patients were older, more likely to be male and heavy smokers. COPD patients with abnormal vs those with normal echocardiography had an increased rate of mod-severe exacerbation like events (1.3 vs 0.6). They also had a higher prevalence of self-reported heart disease, diabetes, abnormal ECG, cardiovascular medication use, higher blood eosinophil and troponin but no difference on lung function, computed tomography-assessed emphysema and gas trapping, symptom burden and health status.</div><div>HF patients with abnormal vs those with normal spirometry had increased exacerbation like-events (16.7 % vs 6.3 % but reach statistical significance). They also had more heart disease, worse lung function by definition and gas trapping, higher blood eosinophil but no difference in symptom burden and health status.</div><div>In two specialized clinics the prevalence of concomitant disease -undiagnosed HF in COPD patients and undiagnosed COPD in HF patients was common. Distinctive features were limited to clinical characteristics, but specific biomarkers cannot be recommended.</div></div>","PeriodicalId":21057,"journal":{"name":"Respiratory medicine","volume":"252 ","pages":"Article 108628"},"PeriodicalIF":3.1,"publicationDate":"2025-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145888937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-30DOI: 10.1016/j.rmed.2025.108626
Yingqi Yang , Xia Tang , Tianchi Zhuang , Chang You , Hongkai Yu , Lu Hu , Haokun Mei , Ting Xu , Haili Ren , Hairong Yu , Yibo Gu , Xiaoying Duan , Ning Li , Minghui Ji
Background
Sleep apnea syndrome (SAS) affects one billion people worldwide and is a potential risk factor for a range of diseases. However, its association with respiratory infections is currently unknown.
Methods
We first employed a multi-model logistic regression approach to control confounding factors and explore the association between SAS and respiratory infections with data from NHANES. Subsequently, a Mendelian randomization (MR) analysis was employed to investigate the causal relationship between SAS and 15 respiratory infections outcomes. Heterogeneity tests were conducted and MR-Egger and MR-PRESSO were used to test for horizontal pleiotropy. Leave-one-out analysis was performed to identify influential SNPs. The study adhered to STROBE-MR guidelines for reporting MR results.
Results
In data from NHANES, we observed that SAS was an independent risk factor for respiratory infections (Model 2: P = 0.031, OR = 1.147, 95 % CI = 1.012–1.299). MR analysis showed that SAS was a risk factor for acute upper respiratory infections (P = 0.014, OR = 1.049, 95 % CI = 1.010–1.090) and other acute lower respiratory infections (P = 0.001, OR = 1.128, 95 % CI = 1.052–1.210). In the reverse MR analysis, COVID-19 (very severe respiratory confirmed vs. population) (P = 0.013, OR = 0.969, 95 % CI = 0.945–0.993), anti-influenza virus subtype H3N2 IgG levels (P = 0.028, OR = 0.974, 95 % CI = 0.952–0.997) and respiratory tuberculosis (P = 0.047, OR = 0.972, 95 % CI = 0.946–1.000) were protective factors for SAS.
Conclusion
SAS is a causal risk factor for respiratory infections and certain infections or specific immune responses may in turn reduce the risk of SAS, revealing a complex bidirectional relationship between them. Future studies are needed to validate the underlying mechanisms.
背景:睡眠呼吸暂停综合征(SAS)影响全球10亿人,是多种疾病的潜在危险因素。然而,它与呼吸道感染的关系目前尚不清楚。方法:我们首先采用多模型逻辑回归方法控制混杂因素,并利用NHANES的数据探讨SAS与呼吸道感染之间的关系。随后,采用孟德尔随机化(MR)分析来调查SAS与15种呼吸道感染结局之间的因果关系。进行异质性检验,采用MR-Egger和MR-PRESSO进行水平多效性检验。进行留一分析以确定有影响的snp。本研究遵循STROBE-MR报告MR结果的指南。结果:在NHANES的数据中,我们观察到SAS是呼吸道感染的独立危险因素(模型2:P = 0.031, OR = 1.147, 95% CI = 1.012-1.299)。MR分析显示SAS是急性上呼吸道感染(P = 0.014, OR = 1.049, 95% CI = 1.010 ~ 1.090)和其他急性下呼吸道感染(P = 0.001, OR = 1.128, 95% CI = 1.052 ~ 1.210)的危险因素。在反向MR分析中,COVID-19(非常严重呼吸道确诊vs.人群)(P = 0.013, OR = 0.969, 95% CI = 0.945-0.993)、抗流感病毒亚型H3N2 IgG水平(P = 0.028, OR = 0.974, 95% CI = 0.952-0.997)和呼吸道结核(P = 0.047, OR = 0.972, 95% CI = 0.946-1.000)是SAS的保护因素。结论:SAS是呼吸道感染的一个因果危险因素,某些感染或特定免疫反应可反过来降低SAS的风险,两者之间存在复杂的双向关系。需要进一步的研究来验证潜在的机制。
{"title":"Association of sleep apnea syndrome with respiratory infections: insights from NHANES and Mendelian randomization","authors":"Yingqi Yang , Xia Tang , Tianchi Zhuang , Chang You , Hongkai Yu , Lu Hu , Haokun Mei , Ting Xu , Haili Ren , Hairong Yu , Yibo Gu , Xiaoying Duan , Ning Li , Minghui Ji","doi":"10.1016/j.rmed.2025.108626","DOIUrl":"10.1016/j.rmed.2025.108626","url":null,"abstract":"<div><h3>Background</h3><div>Sleep apnea syndrome (SAS) affects one billion people worldwide and is a potential risk factor for a range of diseases. However, its association with respiratory infections is currently unknown.</div></div><div><h3>Methods</h3><div>We first employed a multi-model logistic regression approach to control confounding factors and explore the association between SAS and respiratory infections with data from NHANES. Subsequently, a Mendelian randomization (MR) analysis was employed to investigate the causal relationship between SAS and 15 respiratory infections outcomes. Heterogeneity tests were conducted and MR-Egger and MR-PRESSO were used to test for horizontal pleiotropy. Leave-one-out analysis was performed to identify influential SNPs. The study adhered to STROBE-MR guidelines for reporting MR results.</div></div><div><h3>Results</h3><div>In data from NHANES, we observed that SAS was an independent risk factor for respiratory infections (Model 2: P = 0.031, OR = 1.147, 95 % CI = 1.012–1.299). MR analysis showed that SAS was a risk factor for acute upper respiratory infections (<em>P</em> = 0.014, OR = 1.049, 95 % CI = 1.010–1.090) and other acute lower respiratory infections (<em>P</em> = 0.001, OR = 1.128, 95 % CI = 1.052–1.210). In the reverse MR analysis, COVID-19 (very severe respiratory confirmed vs. population) (<em>P</em> = 0.013, OR = 0.969, 95 % CI = 0.945–0.993), anti-influenza virus subtype H3N2 IgG levels (<em>P</em> = 0.028, OR = 0.974, 95 % CI = 0.952–0.997) and respiratory tuberculosis (<em>P</em> = 0.047, OR = 0.972, 95 % CI = 0.946–1.000) were protective factors for SAS.</div></div><div><h3>Conclusion</h3><div>SAS is a causal risk factor for respiratory infections and certain infections or specific immune responses may in turn reduce the risk of SAS, revealing a complex bidirectional relationship between them. Future studies are needed to validate the underlying mechanisms.</div></div>","PeriodicalId":21057,"journal":{"name":"Respiratory medicine","volume":"252 ","pages":"Article 108626"},"PeriodicalIF":3.1,"publicationDate":"2025-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145888334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-29DOI: 10.1016/j.rmed.2025.108623
Benedetta Bondi , Fulvio Braido , Ilaria Baiardini , Federico Di Marco , Carola Montagnino , Martina Buscema , Cesare de Tommaso , Filippo Tarchino , Marcello Mincarini , Anna Maria Riccio , Diego Bagnasco
Background
The relationship between environmental pollution and human health is well-documented, and exposure has been linked to an increased risk of respiratory and psychological diseases. In our clinical practice, a trend of self-medication and self-diagnosis has emerged, defined as independent web searches for self-reported symptoms aimed at obtaining a diagnosis and related treatment in the absence of medical advice.
Objective
This study aims to investigate the relationship between air pollution and public health, focusing on the impact of particulate matter (PM 2.5, PM 10), nitrogen dioxide (NO2), ozone (O3), and other pollutants on respiratory and mental health, and their relationship with web searches for health-related topics.
Methods
The study compares search trends for specific terms (e.g., cough, dyspnea, asthma, etc.), obtained using Google Trends, a tool for assessing public interest in health-related issues, with air main pollutants concentrations collected over the same period in 2024 in Genoa, Liguria region.
Results
Correlation between searches for cough and levels of PM 2.5, O3, benzene, and NO2 was established, while depression also showed a connection to PM 2.5 and benzene.
Discussion
These findings underscore the potential of Google Trends as a valuable resource for epidemiological surveillance. The study highlights the necessity for healthcare systems to adapt to the implications of air quality on health outcomes. It emphasizes the need for innovative approaches, including real-time tracking of air pollution and its health impacts, to enhance patient care and inform clinical practice. The integration of technology and data analytics in healthcare is proposed as a forward-looking strategy to improve therapeutic adherence and patient management in the context of environmental health challenges.
{"title":"Google Trends as a health sentinel. ALERT study: Analyzing Symptoms Perceptions Related To Environmental pollution","authors":"Benedetta Bondi , Fulvio Braido , Ilaria Baiardini , Federico Di Marco , Carola Montagnino , Martina Buscema , Cesare de Tommaso , Filippo Tarchino , Marcello Mincarini , Anna Maria Riccio , Diego Bagnasco","doi":"10.1016/j.rmed.2025.108623","DOIUrl":"10.1016/j.rmed.2025.108623","url":null,"abstract":"<div><h3>Background</h3><div>The relationship between environmental pollution and human health is well-documented, and exposure has been linked to an increased risk of respiratory and psychological diseases. In our clinical practice, a trend of self-medication and self-diagnosis has emerged, defined as independent web searches for self-reported symptoms aimed at obtaining a diagnosis and related treatment in the absence of medical advice.</div></div><div><h3>Objective</h3><div>This study aims to investigate the relationship between air pollution and public health, focusing on the impact of particulate matter (PM 2.5, PM 10), nitrogen dioxide (NO2), ozone (O3), and other pollutants on respiratory and mental health, and their relationship with web searches for health-related topics.</div></div><div><h3>Methods</h3><div>The study compares search trends for specific terms (e.g., cough, dyspnea, asthma, etc.), obtained using Google Trends, a tool for assessing public interest in health-related issues, with air main pollutants concentrations collected over the same period in 2024 in Genoa, Liguria region.</div></div><div><h3>Results</h3><div>Correlation between searches for cough and levels of PM 2.5, O3, benzene, and NO2 was established, while depression also showed a connection to PM 2.5 and benzene.</div></div><div><h3>Discussion</h3><div>These findings underscore the potential of Google Trends as a valuable resource for epidemiological surveillance. The study highlights the necessity for healthcare systems to adapt to the implications of air quality on health outcomes. It emphasizes the need for innovative approaches, including real-time tracking of air pollution and its health impacts, to enhance patient care and inform clinical practice. The integration of technology and data analytics in healthcare is proposed as a forward-looking strategy to improve therapeutic adherence and patient management in the context of environmental health challenges.</div></div>","PeriodicalId":21057,"journal":{"name":"Respiratory medicine","volume":"252 ","pages":"Article 108623"},"PeriodicalIF":3.1,"publicationDate":"2025-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145878863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-26DOI: 10.1016/j.rmed.2025.108610
Alina Ofenheimer , Emiel F.M. Wouters , Christoph Gross , Oliver Helk , Tobias Mraz , Mohammad Azizzadeh , Sylvia Hartl , Robab Breyer-Kohansal , Marie-Kathrin Breyer
Background
The relationship between body compartments and lung function including lung volumes as well as the effects of aging on this relationship remains to be explored. The aim of this study is to evaluate the association between appendicular lean mass index (ALMI), lean mass index (LMI), fat mass index (FMI), and visceral adipose tissue index (VATI) on spirometric and body plethysmographic lung function in the adult and elderly population.
Methods
This observational, cross-sectional study used data from 10.616 adults (≥18–82 years) from the prospective population-based LEAD cohort, conducted between 2011 and 2022 in Vienna, Austria. In total, 1923 participants were elderly (age >65 years). Body compartments were measured by dual-energy X-ray absorptiometry scans and indexed by height squared to account for differences related to body height. Lung function was measured by spirometry (forced expiratory volume in the 1st second; FEV1 and forced vital capacity; FVC) and by body plethysmography (total lung capacity; TLC, fractional residual capacity; FRC, and residual volume; RV).
Findings
In the overall study population, ALMI was positively associated with FEV1, FVC and TLC and negatively with RV and FRC. In contrast, VATI showed a negative association with all lung function parameters investigated. These effects can also be found in the elderly population.
Conclusion
The present study confirms significant associations between body compartments and lung function in adults and in elderly and shows the need to consider body compartments in the assessment and interpretation of lung function results.
{"title":"Relationship of body composition and lung function in adult and elderly males and females","authors":"Alina Ofenheimer , Emiel F.M. Wouters , Christoph Gross , Oliver Helk , Tobias Mraz , Mohammad Azizzadeh , Sylvia Hartl , Robab Breyer-Kohansal , Marie-Kathrin Breyer","doi":"10.1016/j.rmed.2025.108610","DOIUrl":"10.1016/j.rmed.2025.108610","url":null,"abstract":"<div><h3>Background</h3><div>The relationship between body compartments and lung function including lung volumes as well as the effects of aging on this relationship remains to be explored. The aim of this study is to evaluate the association between appendicular lean mass index (ALMI), lean mass index (LMI), fat mass index (FMI), and visceral adipose tissue index (VATI) on spirometric and body plethysmographic lung function in the adult and elderly population.</div></div><div><h3>Methods</h3><div>This observational, cross-sectional study used data from 10.616 adults (≥18–82 years) from the prospective population-based LEAD cohort, conducted between 2011 and 2022 in Vienna, Austria. In total, 1923 participants were elderly (age >65 years). Body compartments were measured by dual-energy X-ray absorptiometry scans and indexed by height squared to account for differences related to body height. Lung function was measured by spirometry (forced expiratory volume in the 1st second; FEV1 and forced vital capacity; FVC) and by body plethysmography (total lung capacity; TLC, fractional residual capacity; FRC, and residual volume; RV).</div></div><div><h3>Findings</h3><div>In the overall study population, ALMI was positively associated with FEV1, FVC and TLC and negatively with RV and FRC. In contrast, VATI showed a negative association with all lung function parameters investigated. These effects can also be found in the elderly population.</div></div><div><h3>Conclusion</h3><div>The present study confirms significant associations between body compartments and lung function in adults and in elderly and shows the need to consider body compartments in the assessment and interpretation of lung function results.</div></div>","PeriodicalId":21057,"journal":{"name":"Respiratory medicine","volume":"252 ","pages":"Article 108610"},"PeriodicalIF":3.1,"publicationDate":"2025-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145850681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-24DOI: 10.1016/j.rmed.2025.108611
Hasti Robbie , Aditya Sharma , Cheng Fang , Christopher Stovin , Joe Bedford , Sam Norton , Michael D. Waller
Background
In the United Kingdom, annual chest radiography is recommended to monitor disease progression in people with cystic fibrosis (CF), yet robust evidence for its utility or relationship with clinical outcomes is lacking. This study explores disease progression on serial chest radiographs, together with relationships of other markers of disease severity.
Method
Single centre, retrospective analysis of annual chest radiographs in adults with CF across ≥10 years. A novel chest x-ray (CXR) scoring system was developed, and annual chest radiographs scored, along with time-matched spirometry and body mass index.
Results
28 patients, aged 33.0 (31.0–39.5) years were included. Mean follow-ups were 11.4 (SD = 1.9) years with a total of 304 CXR scored (mean = 10.9/person). Overall inter-observer agreement was good. No significant or only weak associations were found between changes in total CXR score, or individual CXR variables, and changes in any clinical parameter.
Conclusions
Our new and practical CXR score shows annual changes in CXR in adults with CF are insufficiently sensitive to detect disease progression and show no relationship to changes in other clinical parameters. These data suggest limited value in routine annual CXR for stable adults with CF.
{"title":"Limited clinical utility of annual chest radiographs in adults with cystic fibrosis: A 10-year observational study from a UK centre","authors":"Hasti Robbie , Aditya Sharma , Cheng Fang , Christopher Stovin , Joe Bedford , Sam Norton , Michael D. Waller","doi":"10.1016/j.rmed.2025.108611","DOIUrl":"10.1016/j.rmed.2025.108611","url":null,"abstract":"<div><h3>Background</h3><div>In the United Kingdom, annual chest radiography is recommended to monitor disease progression in people with cystic fibrosis (CF), yet robust evidence for its utility or relationship with clinical outcomes is lacking. This study explores disease progression on serial chest radiographs, together with relationships of other markers of disease severity.</div></div><div><h3>Method</h3><div>Single centre, retrospective analysis of annual chest radiographs in adults with CF across ≥10 years. A novel chest x-ray (CXR) scoring system was developed, and annual chest radiographs scored, along with time-matched spirometry and body mass index.</div></div><div><h3>Results</h3><div>28 patients, aged 33.0 (31.0–39.5) years were included. Mean follow-ups were 11.4 (SD = 1.9) years with a total of 304 CXR scored (mean = 10.9/person). Overall inter-observer agreement was good. No significant or only weak associations were found between changes in total CXR score, or individual CXR variables, and changes in any clinical parameter.</div></div><div><h3>Conclusions</h3><div>Our new and practical CXR score shows annual changes in CXR in adults with CF are insufficiently sensitive to detect disease progression and show no relationship to changes in other clinical parameters. These data suggest limited value in routine annual CXR for stable adults with CF.</div></div>","PeriodicalId":21057,"journal":{"name":"Respiratory medicine","volume":"252 ","pages":"Article 108611"},"PeriodicalIF":3.1,"publicationDate":"2025-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145844127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-23DOI: 10.1016/j.rmed.2025.108605
Christer Janson , Andrei Malinovschi , Magnus Borres , Rosa Faner , Rod Hughes , Anastasios Mangelis , Xiaomeng Ma , Hana Mullerova , Alberto Papi , Helen Reddel , Jose Maria Olaguibel
Background
Allergic sensitization is a hallmark of asthma, linked to increased disease burden. However, its role in chronic obstructive pulmonary disease (COPD) and asthma + COPD remains less understood.
Objective
This cross-sectional study evaluates the prevalence of allergic sensitization and its associations with disease severity, lung function, exacerbations and health status across these conditions in the multinational observational NOVELTY cohort.
Methods
Allergic sensitization was assessed from specific IgE (sIgE) to11 common aeroallergens. Physician-assessed severity, post-bronchodilator FEV1 % predicted, exacerbation history, and health status were evaluated. Mixed-effects multivariable regression models were used to assess associations, adjusted for age, sex, BMI, smoking history, and geographical region.
Results
Baseline sIgE data were available from n = 5389 participants (asthma:2707; asthma + COPD:773; COPD:1909). Allergic sensitization prevalence was 56 % in asthma, 36 % in asthma + COPD, and 19 % in COPD. In asthma, sensitization to any allergen, mites or molds was associated with more severe disease (odds ratios (OR) 1.46 to 2.91) and lower post-BD FEV1 % predicted (coefficients −1.88 % to −8.94 %). Conversely, in COPD, sensitization was associated with higher FEV1 and milder severity. Women were less likely than men to be sensitized across all diagnostic groups. Regional differences were evident, with higher sensitization rates in North America and Europe compared to Asia.
Conclusion
Allergic sensitization shows divergent clinical associations across asthma and COPD, being linked to more severe disease in asthma but higher lung function and milder severity in COPD.
Clinical implication
These findings emphasize the phenotypic heterogeneity of allergic sensitization in airway diseases and support its use in guiding personalized diagnostic and therapeutic strategies.
{"title":"Allergic sensitization in asthma and COPD in the NOVELTY study","authors":"Christer Janson , Andrei Malinovschi , Magnus Borres , Rosa Faner , Rod Hughes , Anastasios Mangelis , Xiaomeng Ma , Hana Mullerova , Alberto Papi , Helen Reddel , Jose Maria Olaguibel","doi":"10.1016/j.rmed.2025.108605","DOIUrl":"10.1016/j.rmed.2025.108605","url":null,"abstract":"<div><h3>Background</h3><div>Allergic sensitization is a hallmark of asthma, linked to increased disease burden. However, its role in chronic obstructive pulmonary disease (COPD) and asthma + COPD remains less understood.</div></div><div><h3>Objective</h3><div>This cross-sectional study evaluates the prevalence of allergic sensitization and its associations with disease severity, lung function, exacerbations and health status across these conditions in the multinational observational NOVELTY cohort.</div></div><div><h3>Methods</h3><div>Allergic sensitization was assessed from specific IgE (sIgE) to11 common aeroallergens. Physician-assessed severity, post-bronchodilator FEV1 % predicted, exacerbation history, and health status were evaluated. Mixed-effects multivariable regression models were used to assess associations, adjusted for age, sex, BMI, smoking history, and geographical region.</div></div><div><h3>Results</h3><div>Baseline sIgE data were available from n = 5389 participants (asthma:2707; asthma + COPD:773; COPD:1909). Allergic sensitization prevalence was 56 % in asthma, 36 % in asthma + COPD, and 19 % in COPD. In asthma, sensitization to any allergen, mites or molds was associated with more severe disease (odds ratios (OR) 1.46 to 2.91) and lower post-BD FEV<sub>1</sub> % predicted (coefficients −1.88 % to −8.94 %). Conversely, in COPD, sensitization was associated with higher FEV<sub>1</sub> and milder severity. Women were less likely than men to be sensitized across all diagnostic groups. Regional differences were evident, with higher sensitization rates in North America and Europe compared to Asia.</div></div><div><h3>Conclusion</h3><div>Allergic sensitization shows divergent clinical associations across asthma and COPD, being linked to more severe disease in asthma but higher lung function and milder severity in COPD.</div></div><div><h3>Clinical implication</h3><div>These findings emphasize the phenotypic heterogeneity of allergic sensitization in airway diseases and support its use in guiding personalized diagnostic and therapeutic strategies.</div></div>","PeriodicalId":21057,"journal":{"name":"Respiratory medicine","volume":"251 ","pages":"Article 108605"},"PeriodicalIF":3.1,"publicationDate":"2025-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145834608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-23DOI: 10.1016/j.rmed.2025.108609
Fuguo Cai , Wei Hong , Chaoliang Xiong , Ningning She , Rui Lu , Yewen Shi , Xiaoyong Ren
Background
Obstructive sleep apnea (OSA) and obesity are interrelated conditions with significant public health implications, but the genetic causal association between them remains unclear. This study investigates their bidirectional causality using Mendelian randomization (MR).
Methods
Genetic data for OSA were obtained from the FinnGen consortium, including 38,998 OSA cases and 336,659 controls, as well as a broader sleep-disorder phenotype comprising 44,299 cases and 329,251 controls. Genetic data for obesity-related traits were sourced from large-scale genome-wide association studies from the GIANT consortium, including body mass index (BMI; n = 681,275), waist–hip ratio (WHR; n = 224,459), and WHR adjusted for BMI (WHRadjBMI; n = 694,649). MR analyses were performed using inverse variance weighting (IVW) as the primary method, with weighted median and MR-Egger analyses for sensitivity assessment.
Results
OSA was causally associated with increased BMI (IVW: OR = 1.275, 95 % CI = 1.070–1.520, p = 0.0065), trunk fat mass (IVW: OR = 1.323, 95 %CI = 1.166–1.501, p = 1.46e-05), and whole-body fat mass (IVW: OR = 1.327, 95 %CI = 1.164–1.512, p = 2.21e-05). Conversely, obesity measures such as BMI (IVW: OR = 1.929, 95 %CI = 1.808–2.059, p = 3.05e-87), trunk fat mass (IVW: OR = 1.630, 95 %CI = 1.515–1.753, p = 4.21e-39), and leg fat mass (IVW: OR = 1.959, 95 %CI = 1.796–2.137, p = 5.93e-52) were causally linked to OSA. No significant association was found between WHR or WHRadjBMI and OSA (p > 0.05).
Conclusion
This study provides genetic evidence of a bidirectional causal relationship between OSA and obesity, emphasizing the role of systemic and regional fat distribution. Integrated management strategies targeting weight reduction and OSA treatment may mitigate the mutual burden of these conditions.
{"title":"Exploring the genetic link between obstructive sleep apnea and obesity: A bidirectional Mendelian randomization study","authors":"Fuguo Cai , Wei Hong , Chaoliang Xiong , Ningning She , Rui Lu , Yewen Shi , Xiaoyong Ren","doi":"10.1016/j.rmed.2025.108609","DOIUrl":"10.1016/j.rmed.2025.108609","url":null,"abstract":"<div><h3>Background</h3><div>Obstructive sleep apnea (OSA) and obesity are interrelated conditions with significant public health implications, but the genetic causal association between them remains unclear. This study investigates their bidirectional causality using Mendelian randomization (MR).</div></div><div><h3>Methods</h3><div>Genetic data for OSA were obtained from the FinnGen consortium, including 38,998 OSA cases and 336,659 controls, as well as a broader sleep-disorder phenotype comprising 44,299 cases and 329,251 controls. Genetic data for obesity-related traits were sourced from large-scale genome-wide association studies from the GIANT consortium, including body mass index (BMI; n = 681,275), waist–hip ratio (WHR; n = 224,459), and WHR adjusted for BMI (WHRadjBMI; n = 694,649). MR analyses were performed using inverse variance weighting (IVW) as the primary method, with weighted median and MR-Egger analyses for sensitivity assessment.</div></div><div><h3>Results</h3><div>OSA was causally associated with increased BMI (IVW: OR = 1.275, 95 % CI = 1.070–1.520, p = 0.0065), trunk fat mass (IVW: OR = 1.323, 95 %CI = 1.166–1.501, p = 1.46e-05), and whole-body fat mass (IVW: OR = 1.327, 95 %CI = 1.164–1.512, p = 2.21e-05). Conversely, obesity measures such as BMI (IVW: OR = 1.929, 95 %CI = 1.808–2.059, p = 3.05e-87), trunk fat mass (IVW: OR = 1.630, 95 %CI = 1.515–1.753, p = 4.21e-39), and leg fat mass (IVW: OR = 1.959, 95 %CI = 1.796–2.137, p = 5.93e-52) were causally linked to OSA. No significant association was found between WHR or WHRadjBMI and OSA (p > 0.05).</div></div><div><h3>Conclusion</h3><div>This study provides genetic evidence of a bidirectional causal relationship between OSA and obesity, emphasizing the role of systemic and regional fat distribution. Integrated management strategies targeting weight reduction and OSA treatment may mitigate the mutual burden of these conditions.</div></div>","PeriodicalId":21057,"journal":{"name":"Respiratory medicine","volume":"252 ","pages":"Article 108609"},"PeriodicalIF":3.1,"publicationDate":"2025-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145834635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-23DOI: 10.1016/j.rmed.2025.108608
Ali Mohamed Ali Ismail , Naglaa Gadallah Mohammed Gadallah , Ahmed Mohamed Abdelhalim Elfahl
Background
Shitali respiratory or pranayamic yogic training might help to improve OSA symptoms but no study investigated the response of OSA to Shitali respiratory training (SRT).
Aim
This pranayama study aimed to investigate the response of OSA patients to SRT.
Methods
Forty from-both-sex OSA patients with polysomnography-based apnea-hypopnea-index (AHI) evidence were included. Patients – aged 35–58 years old - with mild and moderate OSA (5 < AHI <30 events/hour) were included. The closed envelope procedure was used to randomize and assign the OSA patients into the SRT group (received a 12-week daily SRT, n = 20) or control group (served as a waitlist OSA group, n = 20). Outcome measures were blood systole (BS), respiratory rate (RR), visual analogue scale (VAS) that detected partner rating of sleep disturbance by the participants’ snoring, AHI, blood diastole (BD), daytime sleepiness which was assessed by Epworth questionnaire (EQ), and sleeping quality which was assessed Pittsburgh quality of sleep index questionnaire (PQSIQ).
Results
After the 12-week SRT, the within-SRT group comparison of RR, AHI, BS, PQSIQ, BD, EQ, and VAS showed significant improvements. The waitlist OSA group did not show any significant improvement in all measures.
Conclusion
The course of a 12-week SRT is a good treatment to improve RR, AHI, BS, PQSIQ, BD, EQ, and VAS of partner rating of sleep disturbance in patients with OSA.
{"title":"Apnea-hypopnea index, blood pressure, daytime sleepiness, and sleeping quality in obstructive sleep apnea: randomized-controlled responses to Shitali respiratory training","authors":"Ali Mohamed Ali Ismail , Naglaa Gadallah Mohammed Gadallah , Ahmed Mohamed Abdelhalim Elfahl","doi":"10.1016/j.rmed.2025.108608","DOIUrl":"10.1016/j.rmed.2025.108608","url":null,"abstract":"<div><h3>Background</h3><div>Shitali respiratory or pranayamic yogic training might help to improve OSA symptoms but no study investigated the response of OSA to Shitali respiratory training (SRT).</div></div><div><h3>Aim</h3><div>This pranayama study aimed to investigate the response of OSA patients to SRT.</div></div><div><h3>Methods</h3><div>Forty from-both-sex OSA patients with polysomnography-based apnea-hypopnea-index (AHI) evidence were included. Patients – aged 35–58 years old - with mild and moderate OSA (5 < AHI <30 events/hour) were included. The closed envelope procedure was used to randomize and assign the OSA patients into the SRT group (received a 12-week daily SRT, n = 20) or control group (served as a waitlist OSA group, n = 20). Outcome measures were blood systole (BS), respiratory rate (RR), visual analogue scale (VAS) that detected partner rating of sleep disturbance by the participants’ snoring, AHI, blood diastole (BD), daytime sleepiness which was assessed by Epworth questionnaire (EQ), and sleeping quality which was assessed Pittsburgh quality of sleep index questionnaire (PQSIQ).</div></div><div><h3>Results</h3><div>After the 12-week SRT, the within-SRT group comparison of RR, AHI, BS, PQSIQ, BD, EQ, and VAS showed significant improvements. The waitlist OSA group did not show any significant improvement in all measures.</div></div><div><h3>Conclusion</h3><div>The course of a 12-week SRT is a good treatment to improve RR, AHI, BS, PQSIQ, BD, EQ, and VAS of partner rating of sleep disturbance in patients with OSA.</div></div>","PeriodicalId":21057,"journal":{"name":"Respiratory medicine","volume":"252 ","pages":"Article 108608"},"PeriodicalIF":3.1,"publicationDate":"2025-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145834677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}